Evidence map›Paper›PMID 36141261›Full record

ArticleHealthcare (Basel, Switzerland)2022

Vapor-Phase of Essential Oils as a Promising Solution to Prevent

Liliana Fernandes, Bruna Gonçalves, Raquel Costa, Ângela Fernandes, Ana Gomes, Cristina Nogueira-Silva, Sónia Silva, Maria Elisa Rodrigues, Mariana Henriques

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Liliana FernandesCentre of Biological Engineering, LMaS-Laboratório de Microbiologia aplicada à Saúde, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0002-0031-8356
Bruna GonçalvesCentre of Biological Engineering, LMaS-Laboratório de Microbiologia aplicada à Saúde, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.
Raquel CostaAromas Aqua Spa-clínica saúde, Praça 5 Outubro nº 32, Vila Verde, 4730-731 Braga, Portugal.
Ângela FernandesPrimary Care Centre, 4710-374 Braga, Portugal.
Ana GomesFamily Care Unit + Carandá, Primary Care Centre, 4710-374 Braga, Portugal.
Cristina Nogueira-SilvaLife and Health Sciences Research Institute, School of Medicine, University of Minho, 4710-057 Braga, Portugal.
Sónia SilvaCentre of Biological Engineering, LMaS-Laboratório de Microbiologia aplicada à Saúde, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0003-0000-7387
Maria Elisa RodriguesCentre of Biological Engineering, LMaS-Laboratório de Microbiologia aplicada à Saúde, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0001-8823-9494
Mariana HenriquesCentre of Biological Engineering, LMaS-Laboratório de Microbiologia aplicada à Saúde, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal.ORCID 0000-0003-0317-4877
University of Minho · PTClinical Academic Center of Braga · PTHospital Braga · PTInstituto Nacional de Investigação Agrária e Veterinária · PT

Funding

Fundação para a Ciência e Tecnologia 2020.05720.BDFundação para a Ciência e Tecnologia UIDB/04469/2020
6 · The paper itself

Abstract

backgroundVulvovaginal candidiasis (VVC) is a disease with high incidence, a huge impact on the quality of life and health of women, and which represents a great challenge to treat. The growing need to apply antifungal intensive therapies have contributed to an emergence of drug-resistant

methodTherefore, the antimicrobial effect of tea tree, niaouli, white thyme, and cajeput EOs on the planktonic growth of

resultsThe results revealed high antifungal activity of EOs against drug-resistant

conclusionsOverall, this study suggests that the VP-EO may be a promising solution that is able to prevent biofilm-related VVC caused by antifungal-resistant strains.

Indexed as

alternative therapiesantifungal resistancebiofilmessential oilphytotherapeutic applicationvapor-phasevulvovaginal candidiasis

Identifiers

PMID36141261
PMCPMC9498542
OpenAlexW4293525973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.